《科技成果转化为标准指南》推荐性国家标准提供了科技成果转化为标准的需求分析、可行性分析、可 行性评估、标准类型与内容确定等方面的指导。标准的实施有助于推动前沿和关键新兴技术领域成果转 化，促进标准与科技创新、产业创新深度融合。 新华财经北京2月1日电 2月1日起，涉及5G移动通信安全、中小学生午休课桌椅、消费者服务、电梯安 全、地震救援队伍能力等一批重要国家标准开始实施，将为引领和规范新兴产业及未来产业的发展、保 护消费者权益、保障人民群众生命财产安全提供标准支撑。 《5G移动通信网通信安全技术要求》推荐性国家标准确立了5G移动通信网通信安全架构，规定了5G移 动通信网的接入安全、网络安全、用户隐私防护、安全服务等通信安全技术要求及安全功能，并描述了 相关安全流程等。标准的实施有助于提升通信网络与垂直行业融合时的通信安全能力，确保5G移动通 信网的通信安全。 《软件过程能力成熟度模型》推荐性国家标准规定了软件过程能力成熟度框架、战略与治理、开发与交 付、管理与支持和组织保障四组能力域在成熟度五个等级中的能力要求。标准的实施有利于软件企业改 进软件过程、提升管理水平，实现软件行业整体能力水平的提升，促进我国软件 ...

（来源：河北新闻网） 转自：河北新闻网 京津冀发布三项区域协同地方标准 京津冀三地商品流通频繁，过去因数据不互通，同一商品在不同地区经常遇到条码识别障碍问题。《商 品信息数据采集要求》覆盖6大类信息，从商品标识、生产信息到说明信息等38项关键数据全部按统一 规范采集。每个属性信息均需采用中文名称、英文名称、说明、约束条件四方面进行描述。标准实施 后，将实现"一码通三地"，提升供应链透明度与协同效率，促进商品快速上架与数字化市场监管，为区 域企业数字化转型提供技术支撑，助力企业降本增效。京津冀有4.4万余家商品条码企业适用该标准， 将真正让数据"多跑路"、企业"少折腾"。 《突发职业中毒事件调查技术规范》针对氯气、硫化氢、苯等有毒有害气体中毒事件，规范了现场调 查、应急监测流程，填补区域急性职业中毒事件调查与监测技术要求空白。该标准覆盖京津冀200余家 疾控中心、医疗机构及第三方监测机构，有助于提升职业健康应急能力，维护职业人群生命健康。 河北日报讯（记者马彦铭）近日，北京市市场监管局、天津市市场监管委和河北省市场监管局联合发布 《公路钢渣沥青混合料技术规范》《商品信息数据采集要求》《突发职业中毒事件调查技术规 ...

转自：北京青年报客户端 2月1日起，软件过程能力成熟度模型、5G移动通信安全、能源计量器具配备和管理、科技成果转化为标准、学生 体质健康测试器材、中小学生午休课桌椅、适老家具设计、商品条码符号放置、消费者服务、电梯安全、地震救 援队伍能力等一批重要国家标准开始实施。 软件过程能力成熟度模型将有国家标准 《中小学体育器材和场地 第12部分:学生体质健康测试器材》（GB/T 19851.12—2025）推荐性国家标准界定了学 生体质健康测试器材的术语和定义、分类，规定了测试器材的要求、试验方法、检验规则以及标志、包装、运 输、贮存。标准的实施将有助于确保学校体育器材的质量和安全，增强学生体质。 保证中小学生午休课座椅质量 《中小学生午休课桌椅通用技术要求》（GB/T 46016—2025）推荐性国家标准规定了中小学生午休课桌椅的技术 要求、试验方法、检验规则、标志、包装、运输和贮存。标准的实施将有助于保证中小学生午休课座椅的质量， 有效解决非寄宿制学校学生午休需求，保护学生的身心健康。 《软件过程能力成熟度模型》（GB/T 45989—2025）推荐性国家标准规定了软件过程能力成熟度框架、战略与治 理、开发与交付 ...

Company Overview - Nanjing Xinbai (SH 600682) announced the convening of its 11th first board meeting on December 17, 2025, which will include both on-site and remote voting methods [1] - The company has a current market capitalization of 11.1 billion yuan [1] Revenue Composition - For the first half of 2025, Nanjing Xinbai's revenue composition is as follows: - Health and elderly care industry: 33.68% - Pharmaceutical manufacturing: 23.16% - Professional technical services: 15.25% - Medical services: 14.61% - Commodity circulation: 5.89% [1]

Company Overview - Nanjing Xinbai (SH 600682) announced the convening of its 23rd meeting of the 10th Board of Directors on November 28, 2025, via communication voting, which reviewed the proposal to amend the "Working Rules of the Board Audit Committee" [1] Financial Performance - For the first half of 2025, Nanjing Xinbai's revenue composition was as follows: 33.68% from health and elderly care, 23.16% from pharmaceutical manufacturing, 15.25% from professional technical services, 14.61% from medical services, and 5.89% from commodity circulation [1] Market Capitalization - As of the report date, Nanjing Xinbai's market capitalization stood at 10.5 billion yuan [1]

Core Viewpoint - Suhao Fashion announced plans to optimize its asset structure by selling part of its stock holdings in Nanjing Julong, with a maximum of 5.5 million shares to be sold within 12 months from the board's approval date [1] Group 1: Company Actions - The board of Suhao Fashion unanimously approved the proposal to sell part of its stock assets to focus on core business development [1] - The management is authorized to determine the specific timing, trading method, quantity, and price of the sale based on market conditions [1] Group 2: Financial Performance - For the first half of 2025, Suhao Fashion's revenue composition was as follows: 91.44% from merchandise circulation, 6.23% from clothing processing, 1.55% from other businesses, and 0.77% from chemical warehousing [1] - As of the report date, Suhao Fashion's market capitalization stood at 2.5 billion yuan [1]

Group 1 - The company Nanjing Xinbai plans to reduce its repurchased shares by up to 6 million shares, accounting for 0.45% of its total share capital, through centralized bidding trading starting 15 trading days after the announcement until September 26, 2025 [1] - The company will adjust the number of shares to be reduced if there are changes in the number of shares due to stock dividends or capital reserve transfers during this period [1] - After the sale of the repurchased shares, the remaining shares will be arranged for cancellation as per the repurchase plan [1] Group 2 - For the year 2024, the revenue composition of Nanjing Xinbai is as follows: health and elderly care industry 31.77%, pharmaceutical manufacturing 24.3%, professional technical services 17.41%, medical services 13.59%, and commodity circulation 6.14% [1] - As of the report, the market capitalization of Nanjing Xinbai is 11.9 billion yuan [1]

Core Viewpoint - ST Shuntian (600287) has successfully removed the risk warning label and will resume trading under the name Jiangsu Shuntian starting July 16, 2024, following a self-assessment confirming compliance with the conditions for removal [1][2]. Group 1: Stock and Trading Information - The stock will be suspended for one day on July 15, 2024, and will resume trading with a change in the daily price fluctuation limit from 5% to 10% [1]. - The company was under risk warning due to an administrative penalty from the China Securities Regulatory Commission, which has now been resolved [1]. Group 2: Financial Adjustments and Liabilities - The company has corrected accounting errors and restated financial reports for the years 2009-2021 and the balance sheets for 2009-2022 and Q3 2023 [1]. - As of the announcement date, the company has recognized a provision for investor claims amounting to 3.77 million yuan, with an estimated liability of 331.20 million yuan recorded in the 2024 annual report [2]. Group 3: Business Segments and Revenue - The company's main business segments include commodity circulation, garment processing, and chemical warehousing, generating revenues of 3.069 billion yuan, 124 million yuan, and 20 million yuan respectively in 2024 [2]. - The gross profit margins for these segments are 14%, 3.56%, and 16.81% respectively, with domestic revenue at 1.203 billion yuan and overseas revenue at 2.009 billion yuan [2]. Group 4: Recent Performance - In Q1 2025, the company reported a revenue of 643 million yuan and a net profit attributable to shareholders of 8.27 million yuan [3].